Evidence map›Paper›PMID 27892851›Full record

ArticleeLife2016

Lovastatin fails to improve motor performance and survival in

Claudia Villani, Giuseppina Sacchetti, Renzo Bagnati, Alice Passoni, Federica Fusco, Mirjana Carli, Roberto William Invernizzi

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Drug Studies on Rett Syndrome: From Bench to Bedside.Journal of autism and developmental disorders · 2020
    Review
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Claudia VillaniLaboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.ORCID http://orcid.org/0000-0001-6334-9013
Giuseppina SacchettiLaboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Renzo BagnatiAnalytical Instrumentation Unit, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Alice PassoniAnalytical Instrumentation Unit, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Federica FuscoGenetics of Neurodegenerative Diseases Unit, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Mirjana CarliLaboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Roberto William InvernizziLaboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.ORCID http://orcid.org/0000-0002-6017-9781
Mario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies provided evidence for the alteration of brain cholesterol homeostasis in 129.

Indexed as

AnimalsDisease Models, AnimalHydroxymethylglutaryl-CoA Reductase InhibitorsLovastatinMethyl-CpG-Binding Protein 2Mice, Inbred C57BLMice, KnockoutMotionRett SyndromeSurvival AnalysisTreatment OutcomeHydroxymethylglutaryl-CoA Reductase InhibitorsLovastatinMecp2 protein, mouseMethyl-CpG-Binding Protein 224S-hydroxycholesterolcholesterol metabolismgenetic backgroundlovastatinMecp2mouseneuroscienceRett syndrome

Identifiers

PMID27892851
PMCPMC5132339
OpenAlexW2559625605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.